Diabetes drug Invokana Potentially leads to Severe Cases of Fournier’s Gangrene
Pharmaceutical Litigation Attorney’s | Information on Fournier’s Gangrene In August of 2018, the FDA released a Drug Safety report concerning the use of SGLT2 inhibitors for diabetes such as Invokana, Farxiga,...
Valsartan Recalled Due to Impurities causing an Increased Risk of Cancer.
Valsartan Litigation Attorneys | Information on Valsartan & Valsartan HCTZ Discovered late in 2018, it was found that certain generic versions of Valsartan and Valsartan HCTZ may have been manufactured...
Wrongful Death Lawsuit Filed Over Dabigatran AF Bleeding Risks
Drug manufacturer Boehringer Ingelheim is being sued by plaintiff B. Jean Tonioli amid claims that the company’s drug Dabigatran (brand name Pradaxa) caused the wrongful death of her husband when...
Dabigatran Lawsuit Filings Reach 1,343 and Counting
As of August 15, 2013, the number of lawsuits filed over the bleeding risks associated with the use of Dabigatran (Pradaxa) reached 1,343 that are currently pending in MDL No....